Literature DB >> 15219277

Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.

Michael R Kilbourn1.   

Abstract

The long-term reproducibility of measures of in vivo specific binding of radiolabeled forms of (+)-alpha-dihydrotetrabenazine (DTBZ) and d-threo-methylphenidate (MPH) in rat brain was examined. All studies were done using a consistent bolus plus infusion protocol and calculation of equilibrium distribution volume ratios (DVR). Over a period of eight years striatal DVR values for DTBZ binding to the vesicular monoamine transporter 2 (VMAT2) in young adult (8-10 wks old) rats showed very good reproducibility (3.62+/-0.33, N=35). Equivalent values were obtained using either tritiated or carbon-11 labeled DTBZ, and were irrespective of sex of animals. Older animals (78 wks old) showed losses (-45%) of specific binding. Striatal binding of MPH to the dopamine transporter (DAT) showed a similar reproducibility over a five year period (DVR=2.17+/-0.39, N=52), again irrespective of radionuclide or sex. These studies demonstrate that use of a consistent in vivo technique can provide reliable measures of specific binding of radioligands to high affinity sites in the rat brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219277     DOI: 10.1016/j.nucmedbio.2004.02.003

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

1.  Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP.

Authors:  Laura Ravasi; Joji Tokugawa; Toshiyuki Nakayama; Jurgen Seidel; Louis Sokoloff; William C Eckelman; Dale O Kiesewetter
Journal:  Nucl Med Biol       Date:  2011-08-09       Impact factor: 2.408

2.  5-tert-Butyl-2-(4'-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABA A receptor radioligands.

Authors:  Xuehe Li; Yong-Woon Jung; Scott E Snyder; Joseph Blair; Philip S Sherman; Timothy Desmond; Kirk A Frey; Michael R Kilbourn
Journal:  Nucl Med Biol       Date:  2007-11-26       Impact factor: 2.408

3.  Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.

Authors:  Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Catherine Hou; Rajesh Goswami; Datta E Ponde; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2007-04       Impact factor: 2.408

4.  In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations.

Authors:  Michael R Kilbourn; Elizabeth R Butch; Timothy Desmond; Phillip Sherman; Paul E Harris; Kirk A Frey
Journal:  Nucl Med Biol       Date:  2009-10-03       Impact factor: 2.408

5.  Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson's disease: a PET-CT study.

Authors:  Yongtao Zhou; Junwu Zhao; Yaqin Hou; Yusheng Su; Piu Chan; Yuping Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-10       Impact factor: 2.570

6.  Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Authors:  Feng Liu; Haruka Minami; Raul R Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

7.  A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.

Authors:  Zih-Rou Huang; Chia-Ling Tsai; Ya-Yao Huang; Chyng-Yann Shiue; Kai-Yuan Tzen; Ruoh-Fang Yen; Ling-Wei Hsin
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.